PubRank

H Pijl

Author PubWeight™ 55.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Abdominal obesity: metabolic complications and consequences for the liver]. Ned Tijdschr Geneeskd 2001 1.41
2 [New drugs; exenatide and sitagliptin]. Ned Tijdschr Geneeskd 2008 1.40
3 [New drugs; rimonabant]. Ned Tijdschr Geneeskd 2007 1.39
4 [Hirsutism]. Ned Tijdschr Geneeskd 2007 1.38
5 Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol 2012 1.14
6 Adipose tissue as an endocrine organ: impact on insulin resistance. Neth J Med 2003 1.13
7 Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab 2002 1.11
8 Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. Diabetes 2001 1.10
9 Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr 2001 1.07
10 Spontaneous food choice in narcolepsy. Sleep 1996 1.07
11 Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice. Diabetologia 2005 1.07
12 Weight loss in neurodegenerative disorders. J Neurol 2009 1.06
13 Exophthalmos in obesity. Ophthalmic Res 2004 1.04
14 Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 2001 1.01
15 The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells. Biochem Pharmacol 2010 1.00
16 Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications. Rev Neurosci 2007 0.99
17 Circadian distribution of motor activity and immobility in narcolepsy: assessment with continuous motor activity monitoring. Psychophysiology 1995 0.96
18 Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients. Diabetologia 2007 0.95
19 Dynamic metabolomic data analysis: a tutorial review. Metabolomics 2009 0.94
20 Leptin deficiency per se dictates body composition and insulin action in ob/ob mice. J Neuroendocrinol 2008 0.92
21 Gut-brain axis: regulation of glucose metabolism. J Neuroendocrinol 2006 0.91
22 Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease. J Neuroendocrinol 2011 0.90
23 Polymorphisms in the NPY and AGRP genes and body fatness in Dutch adults. Int J Obes (Lond) 2006 0.90
24 Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis. Am J Physiol Endocrinol Metab 2001 0.89
25 Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab 2004 0.89
26 Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans. Diabetes Nutr Metab 2003 0.88
27 The effects of carbohydrate variation in isocaloric diets on glycogenolysis and gluconeogenesis in healthy men. J Clin Endocrinol Metab 2000 0.88
28 No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol 1998 0.87
29 Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice. Diabetologia 2006 0.86
30 Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss. J Clin Endocrinol Metab 1998 0.86
31 Consumption of black and green tea had no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals. Eur J Clin Nutr 2000 0.85
32 Human visceral adipose tissue and the plasminogen activator inhibitor type 1. Int J Obes (Lond) 2007 0.85
33 Effectiveness of a hospital-based vascular screening programme (SMART) for risk factor management in patients with established vascular disease or type 2 diabetes: a parallel-group comparative study. J Intern Med 2010 0.84
34 Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease. Eur J Neurol 2009 0.84
35 Psychological and metabolic responses of carbohydrate craving obese patients to carbohydrate, fat and protein-rich meals. Int J Obes Relat Metab Disord 1997 0.83
36 High fat diet induced hepatic insulin resistance is not related to changes in hypothalamic mRNA expression of NPY, AgRP, POMC and CART in mice. Peptides 2005 0.83
37 Impact of meal timing and frequency on the twenty-four-hour leptin rhythm. Horm Res 2004 0.82
38 Sympathovagal imbalance in hyperthyroidism. Am J Physiol Endocrinol Metab 2001 0.82
39 Leptin. Neth J Med 1996 0.81
40 Serum leptin in normal-weight and obese humans. N Engl J Med 1996 0.81
41 Four weeks high fat feeding induces insulin resistance without affecting dopamine release or gene expression patterns in the hypothalamus of C57Bl6 mice. Brain Res 2008 0.81
42 Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice. Exp Diabetes Res 2011 0.80
43 Glucose homeostasis in abdominal obesity: hepatic hyperresponsiveness to growth hormone action. Am J Physiol Endocrinol Metab 2004 0.80
44 Borderline personality, impulsiveness, and platelet monoamine measures in bulimia nervosa and recurrent suicidal behavior. Biol Psychiatry 1996 0.79
45 Serotoninergic drug-induced weight loss in carbohydrate craving obese patients. Int J Obes Relat Metab Disord 1996 0.79
46 Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and type 2 diabetes susceptibility. Diabet Med 2014 0.79
47 Long-term effect of lifestyle intervention on adiposity, metabolic parameters, inflammation and physical fitness in obese children: a randomized controlled trial. Nutr Diabetes 2011 0.78
48 Influence of obesity and body fat distribution on growth hormone kinetics in humans. Am J Physiol 1999 0.78
49 Factors predicting the blood glucose lowering effect of a 30-day very low calorie diet in obese Type 2 diabetic patients. Diabet Med 2005 0.78
50 Obesity is associated with an altered autonomic nervous system response to nutrient restriction. Clin Endocrinol (Oxf) 2013 0.77
51 Insulin and leptin concentrations in obese humans during long-term weight loss. Neth J Med 1997 0.77
52 Renal clearance of endogenous leptin in hypertensive humans with or without renal artery stenosis. Am J Physiol Endocrinol Metab 2001 0.77
53 The effect of dietary phytosphingosine on cholesterol levels and insulin sensitivity in subjects with the metabolic syndrome. Eur J Clin Nutr 2010 0.76
54 The muscle-liver axis: does aerobic fitness induce intrahepatic protection against non-alcoholic fatty liver disease? J Physiol 2009 0.76
55 Blocking dopamine D2 receptors by haloperidol curtails the beneficial impact of calorie restriction on the metabolic phenotype of high-fat diet induced obese mice. J Neuroendocrinol 2011 0.76
56 Low serum cholesterol and serotonin metabolism. Results may have been affected by confounding. BMJ 1996 0.76
57 Dynamics of the pituitary-adrenal ensemble in hypocretin-deficient narcoleptic humans: blunted basal adrenocorticotropin release and evidence for normal time-keeping by the master pacemaker. J Clin Endocrinol Metab 2002 0.76
58 Predictors of weight loss during treatment with d-fenfluramine. J Intern Med 1997 0.76
59 Hypoandrogenism in obese men: pathophysiological implications versus practical consequences. Neth J Med 2008 0.75
60 Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01). Breast Cancer Res Treat 2015 0.75
61 The insulin sensitizing effect of topiramate involves KATP channel activation in the central nervous system. Br J Pharmacol 2013 0.75
62 Food and mood: a central connection. Neth J Med 1992 0.75
63 Stress, serotonergic function, and mood in users of oral contraceptives. Psychoneuroendocrinology 1995 0.75
64 [Nutrition in psychiatry. Carbohydrates and depression]. TVZ 1992 0.75
65 Estimation of growth hormone secretion rate: impact of kinetic assumptions intrinsic to the analytical approach. Am J Physiol Regul Integr Comp Physiol 2001 0.75
66 Very low calorie diets and recently developed anti-obesity drugs for treating overweight in non-insulin dependent diabetics. Int J Obes Relat Metab Disord 1992 0.75
67 Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1. Diabetologia 2001 0.75
68 [Indications for a favourable effect of intensive insulin therapy for newly-diagnosed type 2 diabetes]. Ned Tijdschr Geneeskd 2008 0.75
69 Neuroendocrine sequelae of visceral fat accumulation: implications for cardiovascular disease and diabetes. Neth J Med 2000 0.75
70 Specific stimulation of brain serotonin mediated neurotransmission by dexfenfluramine does not restore growth hormone responsiveness in obese women. Clin Endocrinol (Oxf) 1996 0.75
71 [Diagnostic image (40). Scurvy]. Ned Tijdschr Geneeskd 2001 0.75
72 Major depression during dexfenfluramine treatment. Int J Obes Relat Metab Disord 1994 0.75
73 [Drug treatment of obesity]. Ned Tijdschr Geneeskd 1996 0.75